Altria Group Inc. ($MO) Stock Forecast: Down 5.0% Today

What is Altria Group Inc.?

Altria Group (MO) is a prominent tobacco company known for brands like Marlboro. The company has been focusing on diversifying its product portfolio to adapt to changing consumer preferences and regulatory environments.

Why is Altria Group Inc. going down?

MO stock is down 5.0% on Jan 29, 2026 19:17

• Altria's stock experienced a bearish movement today due to several factors:
• Declining cigarette sales and intense competition in the nicotine products market, particularly from a competitor's Zyn pouches, have impacted Altria's earnings negatively.
• The company's efforts to diversify into next-generation products, such as FDA-authorized on! Plus pouches, have not been sufficient to offset the challenges faced in the market.
• Additionally, issues with Altria's vaping business, NJOY, including an import ban due to patent infringement, have added to the downward pressure on the stock price.
• Despite reporting better-than-expected sales in Q4 CY2025, the overall market sentiment seems to be influenced more by concerns over earnings and competition in the nicotine products space.

MO Price Chart

MO Technical Analysis

MO News

Altria earnings fall short amid lower cigarette sales and competition for nicotine products

Altria reported flat earnings and lower-than-expected adjusted net income for the fourth quarter, primarily due to declining cigarette sales and intense competition in the nicotine pouch market. The company is facing challenges from unauthorized disposable e-cigarettes and market dominance by Philip Morris International's Zyn pouches, despite Altria's efforts to diversify with its FDA-authorized on! Plus pouches. Altria also took a significant charge on its vaping business, NJOY, after an import ban due to patent infringement.

https://finance.yahoo.com/news/altria-earnings-fall-short-amid-160403158.html

Altria earnings fall short amid lower cigarette sales and competition for nicotine products

Altria's shares dropped after the tobacco giant reported flat earnings, primarily due to decreasing cigarette sales and intense competition in the market for newer nicotine products, such as flavored pouches. The company's fourth-quarter revenue declined by 2% to $5.8 billion, missing Wall Street expectations for adjusted net income per share. Altria is striving to diversify into next-generation products, but faces strong competition, particularly from Philip Morris International's Zyn nicotine pouches.

https://www.oskaloosa.com/news/national_news/altria-earnings-fall-short-amid-lower-cigarette-sales-and-competition-for-nicotine-products/article_ebec992f-85fa-535b-92fa-6aee27b8071d.html

Altria's Q4 Earnings Lag Estimates, Cigarette Volumes Drop

Altria (MO) reported fourth-quarter 2025 results with earnings missing estimates but revenue surpassing them. The company's adjusted earnings remained flat year-over-year at $1.30 per share, while net revenues declined 2.1% due to reduced shipment volumes in the smokeable products segment. Altria projects 2026 adjusted earnings per share in the range of $5.56 to $5.72, signaling a growth of 2.5% to 5.5% from the previous year.

https://www.tradingview.com/news/zacks:d34eb7305094b:0-altria-s-q4-earnings-lag-estimates-cigarette-volumes-drop/

Altria: Q4 Earnings Snapshot

Altria Group reported fourth-quarter net income of $1.12 billion, or 66 cents per share, with adjusted earnings of $1.30 per share, falling short of Wall Street expectations of $1.32 per share. The company's adjusted revenue of $5.08 billion, however, exceeded Street forecasts. Altria projects full-year earnings to be between $5.56 and $5.72 per share.

https://www.theheraldreview.com/business/article/altria-q4-earnings-snapshot-21321752.php

Altria (NYSE:MO) Posts Better-Than-Expected Sales In Q4 CY2025

Altria (NYSE:MO) reported better-than-expected revenue in Q4 CY2025, with sales up 14.5% year-over-year to $5.85 billion, significantly beating analyst estimates. Despite missing adjusted EPS estimates by 1.3%, the company provided strong adjusted EPS guidance for CY2026. Altria, known for Marlboro, highlighted strategic progress in its smoke-free portfolio and strong cash profitability, though its stock traded down immediately after the report.

https://finviz.com/news/291637/altria-nyse-mo-posts-better-than-expected-sales-in-q4-cy2025

Trending Today

Silver ($XAG) Commodity Forecast: Down 5.4% Today

Alcoa Corporation ($AA) Stock Forecast: Down 5.1% Today

Fox Corporation ($FOXA) Stock Forecast: Up 3.6% Today

Patterson-UTI Energy Inc. ($PTEN) Stock Forecast: Up 5.2% Today

Micron Technology Inc. ($MU) Stock Forecast: Up 5.0% Today

Freeport-McMoRan Inc. ($FCX) Stock Forecast: Down 5.3% Today

CF Industries Holdings Inc. ($CF) Stock Forecast: Down 5.2% Today

Xerox Corporation ($XRX) Stock Forecast: Down 5.0% Today

SLM Corporation ($SLM) Stock Forecast: Down 5.3% Today

Digital Turbine, Inc. ($APPS) Stock Forecast: Down 5.0% Today

Altria Group Inc. Price History

30.06.2025 - MO Stock was up 5.0%

• Altria's second-quarter earnings are expected to reflect the impact of NJOY ACE's market exit and soft cigarette volumes, with strong pricing potentially driving results.
• Comparisons with competitor Philip Morris International (PM) underline Altria's pricing power and positive momentum within the tobacco sector.
• A decrease in Altria's short interest ratio suggests a more favorable market sentiment toward the company.
• Positive expectations surround Altria's upcoming earnings, with potential for earnings growth.

30.00.2025 - MO Stock was down 5.2%

• Despite outperforming the broader market in the previous trading session, Altria Group (MO) experienced a strong bearish movement today.
• Concerns surrounding the upcoming Q4 earnings report may have prompted profit-taking or raised investor worries, resulting in the stock's decline.
• Shifting consumer preferences and potential challenges in the tobacco industry could be contributing factors to the bearish trend in Altria's stock price.
• Selling pressure on the stock may be the result of investors comparing Altria's performance to its peers in the consumer staples sector.

21.00.2025 - MO Stock was down 1.5%

• The stock of Altria Group (MO) showed a decline of -0.62% in its price today.
• The negative market movement towards Altria Group could be linked to the stance taken by major investors.
• Despite the overall market's upward movement, Altria Group's stock dropped, indicating a deviation from the general trend.
• The positive coverage initiation for a competitor, Philip Morris International, might have influenced investor sentiment towards Altria Group.

23.11.2024 - MO Stock was up 2.5%

• Altria's stock price increased by 1.6%, reflecting strong bullish momentum.
• The positive movement may be linked to expectations of growth, favorable market conditions, or company-specific developments.
• Investors seem to be responding favorably to recent updates from Altria, leading to a rise in the stock price.
• Overall, Altria's performance suggests that investors have confidence and optimism regarding the company's future prospects.

29.00.2026 - MO Stock was down 5.0%

• Altria's stock experienced a bearish movement today due to several factors:
• Declining cigarette sales and intense competition in the nicotine products market, particularly from a competitor's Zyn pouches, have impacted Altria's earnings negatively.
• The company's efforts to diversify into next-generation products, such as FDA-authorized on! Plus pouches, have not been sufficient to offset the challenges faced in the market.
• Additionally, issues with Altria's vaping business, NJOY, including an import ban due to patent infringement, have added to the downward pressure on the stock price.
• Despite reporting better-than-expected sales in Q4 CY2025, the overall market sentiment seems to be influenced more by concerns over earnings and competition in the nicotine products space.

02.00.2026 - MO Stock was up 0.6%

• Silver Oak Securities Incorporated significantly increased its holdings in Altria Group, Inc., indicating growing confidence in the company's future prospects.
• Despite facing challenges such as declining cigarette volumes and failed investments, Altria's strong dividend yield and share buyback program are likely driving investor interest and contributing to the bullish movement.
• The reduction in stake by Banque Pictet & Cie SA in Philip Morris International Inc. may have redirected some funds towards Altria, further boosting its stock performance.
• Overall, the positive investor sentiment towards Altria, coupled with strategic financial decisions, seems to have propelled the stock to a strong bullish movement today.

22.07.2025 - MO Stock was up 0.0%

• Altria Group's stock, MO, demonstrated a notable bullish trend today, achieving a new 52-week high. This uptick is likely linked to a few key factors:
• Strong earnings growth: Positive financial outcomes and promising growth prospects have attracted investors to the stock.
• Success in the oral tobacco sector: The company's accomplishments in the oral tobacco market may have bolstered investor confidence.
• Growing market trust: Investors' increasing faith in Altria Group's long-term strategy has added to the upward momentum of the stock.

02.03.2025 - MO Stock was down 5.2%

• Altria (MO) saw a rise of +1.83% in the recent trading session, different from the overall market trend.
• The upturn in Altria's stock price may be linked to positive internal developments outweighing the broader market performance.
• Investors seem optimistic about growth prospects or strategic moves by Altria, driving the stock's climb amidst market pessimism.
• Monitoring Altria for updates is crucial to assess the sustainability of this price surge within the broader market context.

06.00.2026 - MO Stock was down 0.5%

• A significant increase in institutional stake in PM by Spirepoint Private Client LLC could have triggered profit-taking by other investors, leading to a bearish movement in the stock.
• The ESOP-related offering of common shares by Philip Morris International to support its shift towards smoke-free products might have raised concerns among investors about the company's financial strategy and future growth prospects.
• The negative outlook on Altria, a competitor of PM, due to declining cigarette volume and revenue, could have created a bearish sentiment in the tobacco industry, impacting PM's stock price negatively.
• The overall uncertainty surrounding the tobacco industry's future, with companies like Altria and PM transitioning to smoke-free products amidst regulatory challenges, might have contributed to the bearish movement in PM's stock today.

30.09.2025 - MO Stock was down 8.4%

• The decline in Altria's stock today could be linked to varied expectations for its upcoming Q3 earnings release:
• Concerns about the possibility of falling short of earnings estimates, despite its strong pricing power and focus on smoke-free alternatives, may have influenced the bearish trend.
• Analyst forecasts and a lack of positive indicators for surpassing earnings estimates could have tempered investor confidence, contributing to the downward movement.
• Comparisons with Philip Morris and the speculative focus on important metrics in the earnings report might have introduced uncertainty, exacerbating the negative impact on the stock price.

30.09.2025 - MO Stock was down 8.0%

• Despite exceeding Q3 earnings expectations, Altria (MO) faced significant downward pressure in the market.
• Comparisons with another industry player in light of industry changes may have prompted concerns over Altria's competitive standing and future growth prospects.
• The predicted robust Q3 performance driven by pricing strategies and non-smoking initiatives possibly wasn't enough to counter broader market sentiments and external factors affecting the stock.
• The analysts' forecasts for key performance indicators may have fallen short of investor forecasts, contributing to a negative market shift for Altria (MO) despite favorable earnings surprises.

30.09.2025 - MO Stock was down 7.8%

• A decrease in smokeable and oral tobacco sales during the third quarter resulted in a year-over-year revenue decline for Altria Group, negatively impacting investor sentiment.
• Despite surpassing earnings projections and demonstrating cost-cutting measures, reduced sales of cigarettes and oral tobacco affected the company's overall revenue performance, leading to a decrease in the stock price.
• Investor sentiment towards Altria may have been influenced by the evolving tobacco industry landscape, particularly when compared to Philip Morris, further contributing to the downward trend in the stock.
• Expectations of robust Q3 results based on pricing power and advancements in smoke-free products were not met in terms of revenue, potentially disappointing investors and prompting the bearish movement in the stock price.